GFAP and Cognitive impairment: To evaluate whether cognitive impairment detected in rats inoculated with FAβ1–42 peptide solution (1 μg/μL) was correlated with astrogliosis, we performed GFAP fluorescence labeling of brain tissues of rats harvested at 14 days post-infusion.